Evidence map›Paper›PMID 29683850›Full record

Trial reportAIDS (London, England)2018

Comparative effectiveness of novel nonmonetary incentives to promote HIV testing.

Gabriel Chamie, Elisabeth M Schaffer, Alex Ndyabakira, Devy M Emperador, Dalsone Kwarisiima, Carol S Camlin, Diane V Havlir, James G Kahn, Moses R Kamya, Harsha Thirumurthy

2 registry-linked trialsAbstract readRandomized Controlled Trial
In one paragraph

Trial report in AIDS (London, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 21 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02890459 nacompletednot on this map

Innovative Incentive Strategies for Sustainable HIV Testing and Antiretroviral Treatment

TypeinterventionalSponsorUniversity of California, San FranciscoRan2016 to 2020Enrolled3,580ConditionsHIV/AIDSArmsPrize incentive - Low, Prize incentive - High, Escalating payment incentive, Travel Voucher, Standard care
NCT04772469 nacompletednot on this mapstarted 2021, after this paper: background citation

Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in Men

TypeinterventionalSponsorUniversity of California, San FranciscoRan2021 to 2023Enrolled934ConditionsHuman Immunodeficiency Virus, Acquired Immunodeficiency Syndrome, HIV Infections, Sexually Transmitted Diseases, ViralArmsProvision of multiple self-tests, Small monetary incentives, Use of SMS/text reminders to motivate adherence to ART or PrEP
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Gabriel ChamieUniversity of California, San Francisco, California.
Elisabeth M SchafferUniversity of North Carolina at Chapel Hill, North Carolina, USA.
Alex NdyabakiraMakerere University-UCSF Research Collaboration, Mbarara.
Devy M EmperadorUniversity of California, San Francisco, California.
Dalsone KwarisiimaMakerere University Joint AIDS Program.
Carol S CamlinUniversity of California, San Francisco, California.
Diane V HavlirUniversity of California, San Francisco, California.
James G KahnUniversity of California, San Francisco, California.
Moses R KamyaMakerere University College of Health Sciences, Kampala, Uganda.
Harsha ThirumurthyUniversity of Pennsylvania, Philadelphia, Pennsylvania, USA.

Funding

Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
Research Services CoreP2CHD050924 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KAREN B GUZZO · 2015 to 2026
$9.6M
Innovative incentive strategies for sustainable HIV testing and linkage to careR01MH105254 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHAMIE, GABRIEL, THIRUMURTHY, HARSHA · 2015 to 2019
$3.0M
NIAID NIH HHS P30 AI050410NICHD NIH HHS P2C HD050924NIMH NIH HHS R01 MH105254
6 · The paper itself

Abstract

objectiveTo assess the comparative effectiveness of alternative incentive-based interventions to promote HIV testing among men.

designRandomized clinical trial.

methodsWe enumerated four Ugandan parishes and enrolled men at least 18 years. Participants were randomized to six groups that received incentives of varying type and amount for HIV testing at a 13-day community health campaign. Incentive types were: gain-framed (control): participants were told they would receive a prize for testing; loss-framed: participants were told they had won a prize, shown several prizes, asked to select one, then told they would lose the prize if they did not test; lotteries: those who tested had a chance to win larger prizes. Each incentive type had a low and high amount (∼US$1 and US$5/participant). The primary outcome was HIV-testing uptake at the community health campaign.

resultsOf 2532 participants, 1924 (76%) tested for HIV; 7.6% of those tested were HIV-positive. There was no significant difference in testing uptake in the two lottery groups (78%; P = 0.076) or two loss-framed groups (77%; P = 0.235) vs. two gain-framed groups (74%). Across incentive types, testing did not differ significantly in high-cost (76%) vs. low-cost (75%; P = 0.416) groups. Within low-cost groups, testing uptake was significantly higher in the lottery (80%) vs. gain-framed (72%; P = 0.009) group.

conclusionOverall, neither offering incentives via lotteries nor framing incentives as losses resulted in significant increases in HIV testing compared with standard gain-framed incentives. However, when offering low-cost incentives to promote HIV testing, providing lottery-based rewards may be a better strategy than gain-framed incentives.

Indexed as

MotivationAdultAgedBehavior TherapyFacilities and Services UtilizationHIV InfectionsHumansMaleMass ScreeningMiddle AgedUganda

Identifiers

PMID29683850
PMCPMC6112858

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.